P E Hanna - JoVE Visualize

Showing results (31-40 of 37) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 37 results.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 1, 1996

Arylamine N-acetyltransferases. Expression in Escherichia coli, purification, and substrate specificities of recombinant hamster monomorphic and polymorphic isozymesC R Wagner, C P Bergstrom, K R Koning, et al.

Acta Crystallographica. Section C, Crystal Structure Communications|May 15, 1997

Heterocyclic N-acetoxyarylamines, models for the putative ultimate carcinogens of aromatic amines: 2-acetoxyamino-5-phenylpyridine and 2-acetoxyaminopyridineW H Ojala, R A Iyer, P E Hanna, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1981

Thioredoxin-dependent sulfoxide reduction by rat renal cytosolM W Anders, J H Ratnayake, P E Hanna, et al.

Journal of Medicinal Chemistry|January 1, 1985

Mechanism-based inactivation of N-arylhydroxamic acid N,O-acyltransferase by 7-substituted-N-hydroxy-2-acetamidofluorenesV C Marhevka, N A Ebner, R D Sehon, et al.

Journal of the American Veterinary Medical Association|August 15, 1991

Surgical treatment of a congenital bronchoesophageal fistula in a dogA W Basher, P M Hogan, P E Hanna, et al.

Protein Expression and Purification|June 1, 1997

Overexpression and large-scale purification of recombinant hamster polymorphic arylamine N-acetyltransferase as a dihydrofolate reductase fusion proteinK R Sticha, C A Sieg, C P Bergstrom, et al.

The Prostate|February 18, 1998

Cyclic hydroxamic acid inhibitors of prostate cancer cell growth: selectivity and structure activity relationshipsK P Roberts, R A Iyer, G Prasad, et al.

Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 37 results.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 1, 1996

Arylamine N-acetyltransferases. Expression in Escherichia coli, purification, and substrate specificities of recombinant hamster monomorphic and polymorphic isozymesC R Wagner, C P Bergstrom, K R Koning, et al.

Acta Crystallographica. Section C, Crystal Structure Communications|May 15, 1997

Heterocyclic N-acetoxyarylamines, models for the putative ultimate carcinogens of aromatic amines: 2-acetoxyamino-5-phenylpyridine and 2-acetoxyaminopyridineW H Ojala, R A Iyer, P E Hanna, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1981

Thioredoxin-dependent sulfoxide reduction by rat renal cytosolM W Anders, J H Ratnayake, P E Hanna, et al.

Journal of Medicinal Chemistry|January 1, 1985

Mechanism-based inactivation of N-arylhydroxamic acid N,O-acyltransferase by 7-substituted-N-hydroxy-2-acetamidofluorenesV C Marhevka, N A Ebner, R D Sehon, et al.

Journal of the American Veterinary Medical Association|August 15, 1991

Surgical treatment of a congenital bronchoesophageal fistula in a dogA W Basher, P M Hogan, P E Hanna, et al.

Protein Expression and Purification|June 1, 1997

Overexpression and large-scale purification of recombinant hamster polymorphic arylamine N-acetyltransferase as a dihydrofolate reductase fusion proteinK R Sticha, C A Sieg, C P Bergstrom, et al.

The Prostate|February 18, 1998

Cyclic hydroxamic acid inhibitors of prostate cancer cell growth: selectivity and structure activity relationshipsK P Roberts, R A Iyer, G Prasad, et al.

Pageof 4